Informations sur le produit
PF 04531083 is a drug candidate for the treatment of pain and inflammation. It is a sodium channel modulator that has been shown to have an anti-inflammatory effect in animal models of inflammatory pain. This compound also blocks voltage-gated sodium channels and may be effective against chronic pain. PF 04531083 has been evaluated in clinical trials for the treatment of various types of pain, including neuropathic pain, which is caused by damage to the nervous system. The drug is being studied as a potential therapy for patients with HIV infection-related oral mucositis, as well as in patients undergoing radiotherapy or chemotherapy. This compound has not yet been tested in humans, but it has shown no toxic effects in animals at high doses.
